Thursday, March 17, 2011

Miracles and wonders: cancer-smart phones, tic-tac size pacemakers

Cancer detection system.

Everyday something amazing comes out of the medical labs and research centers.

Scientists at the Massachusetts General Hospital that have integrated a microNMR device that accurately detects cancer cells to a smartphone. Though just a prototype, this device enables a clinician to extract small amounts of cells from a mass inside of a patient, analyze the sample on the spot, acquire the results in an hour, and pass the results to other clinicians and into medical records rapidly. How much does the device cost to make? $200.

Researchers at Wake Forest Baptist Medical Center have become the first in the world to use patients’ own cells to build tailor-made urinary tubes and successfully replace damaged tissue. They replaced damaged segments of urinary tubes (urethras) in five boys. Tests to measure urine flow and tube diameter showed that the engineered tissue remained functional throughout the six-year follow-up period.

Medtronic, the world's largest medical-device maker, is using microelectronics and chip manufacturing to shrink pacemakers — implanted devices that regulate the heart's rhythm. Whereas current pacemakers are about as big as a silver dollar, Medtronic's device would be smaller than a tic tac. At that size, the device would be small enough to be inserted via catheter, rather than invasive surgery.

Scientists from the Russian city of Chelyabinsk have developed “a bio-artificial liver” which not only cleans the blood, but is also capable of “jumpstarting” a sick body. Several successful operations have already been conducted at a local hospital.

A joint team of Indian and Australian scientists claims to have achieved a breakthrough by creating an antibody which could be used for developing a "medical smart bomb" that would help seek out and eradicate the root of cancer — the stem cells. 

The promising results of a gene-therapy trial have offered new hope to people with Parkinson's disease. The controversial approach uses virus particles to infuse new genes into a patient's own cells. The goal of the therapy is to provide patients' cells with the blueprints to make proteins that have a therapeutic effect. In this case, the blueprint encoded an enzyme called GAD that would act like a chemical form of deep-brain stimulation, avoiding the need for electrodes, wires and battery packs.

No comments:

Post a Comment